Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Accenture
Baxter
Express Scripts
Chubb
Fuji

Generated: August 20, 2019

DrugPatentWatch Database Preview

Litigation Details for The People of The State of New York v. Actavis plc (S.D.N.Y. 2014)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

The People of The State of New York v. Actavis plc (S.D.N.Y. 2014)

Docket ➤ Sign Up Date Filed 2014-09-15
Court District Court, S.D. New York Date Terminated 2015-11-30
Cause 15:2 Antitrust Litigation Assigned To Robert Workman Sweet
Jury Demand None Referred To
Parties ACTAVIS PLC; FOREST LABORATORIES, L.L.C.; MYLAN INC.; THE PEOPLE OF THE STATE OF NEW YORK
Patents 5,061,703
Attorneys Charles Moore; Elinor Rose Hoffmann; Eric Jonathan Stock; Jack Pace; Jaime M. Crowe; Jeremy R. Kasha; John Mark Gidley; Jonathan Lutinski; Martin Michael Toto; Noah Brumfield; Peter J. Carney; Saami Zain; Seth C. Silber; Zachary William Biesanz
Firms New York State Office of the Attorney General; New York State Office of the Attorney General (NYC); New York State Office of the Attorney General, (Antitrust Bureau); State of New York, Office of the Attorney General; White & Case; White & Case LLP (DC); Wilson Sonsini Goodrich & Rosati(NYC); Wilson Sonsini Goodrich and Rosati
Link to Docket External link to docket
Small Molecule Drugs cited in The People of The State of New York v. Actavis plc
The small molecule drugs covered by the patent cited in this case are ➤ Sign Up , ➤ Sign Up , and ➤ Sign Up .

Details for The People of The State of New York v. Actavis plc (S.D.N.Y. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-10-30 52 license to U.S. Patent No. 5,061,703, covering Namenda IR tablets, and that patent expires on April … 1981) (“Simply stated, a patent holder is permitted to maintain his patent monopoly through conduct …645 F.2d at 1204 (“patent holder is permitted to maintain his patent monopoly through conduct…..... 4 C. Forest Labs Has Patent and Regulatory Exclusivities for the Sale of …Association). C. Forest Labs Has Patent and Regulatory Exclusivities for the Sale of External link to document
2014-12-10 71 ................................16 U.S. Patent No. 5,061,703.........................................…. Forest Labs exclusively licenses U.S. Patent No. 5,061,703, which covers the twice-a-day Namenda IR…require a patent holder to forfeit the exclusionary power inherent in his patent the instant his patent monopoly…1195, 1204 (2d Cir. 1981) (patent owner has no duty to license its patents). Second, the Bureau…at 1204 (“Simply stated, a patent holder is permitted to maintain his patent monopoly through conduct External link to document
2014-12-10 74 ................................16 U.S. Patent No. 5,061,703.........................................…. Forest Labs exclusively licenses U.S. Patent No. 5,061,703, which covers the twice-a-day Namenda IR…require a patent holder to forfeit the exclusionary power inherent in his patent the instant his patent monopoly…1195, 1204 (2d Cir. 1981) (patent owner has no duty to license its patents). Second, the Bureau…at 1204 (“Simply stated, a patent holder is permitted to maintain his patent monopoly through conduct External link to document
2014-12-11 80 Forest obtained an exclusive license to U.S. Patent No. 5,061,703 held by Germany’s Merz Pharma GmbH &…the ’703 patent, expires on April 11, 2015. U.S. Patent and Trademark Office, Patent Term Extensions… of a patent. The Act allows a branded drug manufacturer to seek up to a five-year patent extension…firm’s patent is invalid or not infringed; and (ii) to ensure that the branded firm’s patent exclusivity…Act, like the patent laws, incentivizes research by helping to preserve lawful patent and regulatory External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Colorcon
Boehringer Ingelheim
Harvard Business School
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.